Artwork

Content provided by American College of Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

48. Biosimilars

39:30
 
Share
 

Manage episode 356586072 series 2681489
Content provided by American College of Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week we discuss what a biosimilar is, why they’re causing such controversy and why they’ve taken seven years, since the FDA approved Amgevita, to come to market. We review the evidence behind the safety and efficacy of these drugs, the data from switching from a bio-originator to a biosimilar, and how the approval of the drugs may lower the health care costs and improve access to these medications.

  continue reading

91 episodes

Artwork

48. Biosimilars

ACR on Air

17 subscribers

published

iconShare
 
Manage episode 356586072 series 2681489
Content provided by American College of Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week we discuss what a biosimilar is, why they’re causing such controversy and why they’ve taken seven years, since the FDA approved Amgevita, to come to market. We review the evidence behind the safety and efficacy of these drugs, the data from switching from a bio-originator to a biosimilar, and how the approval of the drugs may lower the health care costs and improve access to these medications.

  continue reading

91 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide